Evaluations of Effects of Intra-Erythrocyte Dexamethasone Sodium Phosphate on Neurological Symptoms in Ataxia-Teleangiectasia Patients

Trial Profile

Evaluations of Effects of Intra-Erythrocyte Dexamethasone Sodium Phosphate on Neurological Symptoms in Ataxia-Teleangiectasia Patients

Completed
Phase of Trial: Phase II

Latest Information Update: 19 May 2015

At a glance

  • Drugs Dexamethasone (Primary)
  • Indications Ataxia telangiectasia
  • Focus Therapeutic Use
  • Acronyms IEDAT01
  • Most Recent Events

    • 19 May 2015 According to an EryDel media release, results of this 2 year extension study were published in Neurology Neuroimmunology & Neuroinflammation.
    • 19 May 2015 Results published in an EryDel media release.
    • 05 Feb 2013 Additional identifiers (EudraCT2010-022315-19; IEDAT-ERY01-2010) added.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top